Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Cole

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Biochemical and Biophysical Research Communications|July 27, 2001
Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding siteE U Kurz, S P Cole, R G Deeley
Molecular Pharmacology|May 1, 1981
Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liverS P Cole, D T Zelt, G S Marks
Toxicology|September 15, 2001
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transportersE M Leslie, R G Deeley, S P Cole
Journal of Clinical Immunology|November 1, 1996
P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinomaB Savas, S P Cole, T Tsuruo, et al.
Biochemical Pharmacology|October 11, 1996
Multidrug resistance mediated by the multidrug resistance protein (MRP) geneD Lautier, Y Canitrot, R G Deeley, et al.
The Journal of Social Psychology|November 15, 1997
Physical fitness as a function of psychological and situational factorsS Nowicki, D Adame, T C Johnson, et al.
Natural Immunity|July 1, 1992
P-glycoprotein-mediated multidrug resistance and cytotoxic effector cellsB Savas, S P Cole, T F Akoglu, et al.
British Journal of Cancer|April 1, 1992
Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell lineS P Cole, M J Pinkoski, G Bhardwaj, et al.
Biochemistry|May 13, 1997
Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicingQ Yu, S E Mirski, K E Sparks, et al.
Analytical Biochemistry|August 15, 1985
Two-dimensional electrophoretic display of restriction fragments from genomic DNAA C Peacock, S L Bunting, S P Cole, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|July 27, 2001
Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding siteE U Kurz, S P Cole, R G Deeley
Molecular Pharmacology|May 1, 1981
Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liverS P Cole, D T Zelt, G S Marks
Toxicology|September 15, 2001
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transportersE M Leslie, R G Deeley, S P Cole
Journal of Clinical Immunology|November 1, 1996
P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinomaB Savas, S P Cole, T Tsuruo, et al.
Biochemical Pharmacology|October 11, 1996
Multidrug resistance mediated by the multidrug resistance protein (MRP) geneD Lautier, Y Canitrot, R G Deeley, et al.
The Journal of Social Psychology|November 15, 1997
Physical fitness as a function of psychological and situational factorsS Nowicki, D Adame, T C Johnson, et al.
Natural Immunity|July 1, 1992
P-glycoprotein-mediated multidrug resistance and cytotoxic effector cellsB Savas, S P Cole, T F Akoglu, et al.
British Journal of Cancer|April 1, 1992
Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell lineS P Cole, M J Pinkoski, G Bhardwaj, et al.
Biochemistry|May 13, 1997
Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicingQ Yu, S E Mirski, K E Sparks, et al.
Analytical Biochemistry|August 15, 1985
Two-dimensional electrophoretic display of restriction fragments from genomic DNAA C Peacock, S L Bunting, S P Cole, et al.
Pageof 16